Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review
Cureus · 26.06.2023
DOI: 10.7759/cureus.40969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 26.06.2023. Verfasst von Divyanshu Dhamija und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cannabis is frequently used by people who self-medicate for the signs of mental health conditions. Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental illness, has been linked to increased cannabis use. However, compared to other mental disorders, cannabis use by people with ADHD has received much less research. The main goal of this systematic review was to understand the nature of the relationships between cannabis use and ADHD symptoms. We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct the systematic review. We included papers published within the previous ten years from online searches on PubMed, PubMed Central (PMC), Google Scholar, and ScienceDirect until January 1st, 2023. The inclusion-exclusion criteria led to the initial selection of 136 studies. We selected twenty research articles after screening and assessing them using quality assessment techniques. These articles included two non-randomized control trials, one cross-sectional study, one meta-analysis, and sixteen observational cohorts. It can be advantageous for people with ADHD and their medical professionals to understand better how ADHD patients use cannabis and its potential risks and advantages on cannabis use disorder, ADHD symptoms, and executive dysfunction. This article further emphasizes the necessity of thorough research to comprehend cannabis use in ADHD patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
- Psychiatry, St. Martinus University, Pontiac, USA.
- Internal Medicine, Richmond University Medical Center, Staten Island, USA.
- Internal Medicine, Medical College Baroda, Vadodara, IND.
- Radiology, Bharati Vidyapeeth, Pune, IND.
- Internal Medicine, Qingdao University College of Medical Science, Qingdao, CHN.
Zitieren
APA
Dhamija, D., Bello, A. O., Khan, A. A., Gutlapalli, S. D., Sohail, M., Patel, P. A., Midha, S., Shukla, S., & Mohammed, L. (2023). Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.40969
Vancouver
Dhamija D, Bello AO, Khan AA, Gutlapalli SD, Sohail M, Patel PA, et al. Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review. Cureus. 2023. doi:10.7759/cureus.40969
BibTeX
@article{Dhamija2023,
author = {Dhamija, Divyanshu and Bello, Adedamola O and Khan, Asma A and Gutlapalli, Sai Dheeraj and Sohail, Mehvish and Patel, Priyansh A and Midha, Sidharth and Shukla, Surmai and Mohammed, Lubna},
title = {Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.40969}
}
EUVIMED